Quality measures are used to track patient care, connect outcomes with processes, and meet third-party payer requirements, such as the Merit-based Incentive Payment System (MIPS). Reg-ent allows participants to track performance and benchmark against peers in Reg-ent for specialty-specific (i.e., QCDR) and public (i.e., QPP) measures.

Qualified Clinical Data Registry (QCDR) Measures

Download all Qualified Clinical Data Registry (QCDR) Measure PDFs.

Age-related Hearing Loss

Allergic Rhinitis

Bell’s Palsy


Otitis Media with Effusion (OME)

Tympanostomy Tubes


Quality Payment Program (QPP) Public Measures

Download all Quality Payment Program (QPP) Public Measure PDFs.

Acute Otitis Externa
QPP093: Acute Otitis Externa (AOE): Systemic Antimicrobial Therapy – Avoidance of Inappropriate Use+

Adult Sinusitis
QPP331: Adult Sinusitis: Antibiotic Prescribed for Acute Viral Sinusitis (Overuse)+
QPP332: Adult Sinusitis: Appropriate Choice of Antibiotic: Amoxicillin With or Without Clavulanate Prescribed for Patients with Acute Bacterial Sinusitis (Appropriate Use)+

QPP398: Optimal Asthma Control*+

QPP155: Falls: Plan of Care+

QPP130: Documentation of Current Medications in the Medical Record^+
QPP238: Use of High-Risk Medications in Older Adults^+

Otitis Media with Effusion
QPP464: Otitis Media with Effusion: Systemic Antimicrobials – Avoidance of Inappropriate Use+

Preventive Care & Screening
QPP110: Preventive Care and Screening: Influenza Immunization^
QPP111: Pneumococcal Vaccination Status for Older Adults^
QPP128: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan^
QPP226: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention^
QPP317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented^
QPP402: Tobacco Use and Help with Quitting Among Adolescents
QPP431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling

Respiratory Diseases
QPP066: Appropriate Testing for Pharyngitis^+

Skin Cancer
QPP440: Skin Cancer: Biopsy Reporting Time – Pathologist to Clinician+

QPP355: Unplanned Reoperation within the 30 Day Postoperative Period*+
QPP356: Unplanned Hospital Readmission within 30 Days of Principal Procedure*+
QPP357: Surgical Site Infection (SSI)*+

Sleep Apnea
QPP277: Sleep Apnea: Severity Assessment at Initial Diagnosis
QPP279: Sleep Apnea: Assessment of Adherence to Positive Airway Pressure Therapy


QPP318: Screening for Future Fall Risk^
QPP047: Advance Care Plan+
QPP261: Referral for Otologic Evaluation for Patients with Acute or Chronic Dizziness+
QPP265: Biopsy Follow-Up+
QPP374: Closing the Referral Loop: Receipt of Specialist Report^+


*Denotes Outcome Measure
+Denotes High Priority Measure
^Denotes eCQM


AAO-HNSF 2024 Annual Meeting & OTO EXPO Early Registration Ends July 31Learn More